#trialkey
LightNews LightNews
trialkeyai.bsky.social
Join Saurabh Jain, Executive Chairman of Opyl, as he presents at the ShareCafe Webinar, showcasing TrialKey.

When: 12:30 PM AEDT, Friday, 29 November 2024
Register here to attend:
us02web.zoom.us/webinar/regi... 

#opyl #trialkey #clinicaltrials #investment #asx #biotech #pharma #biotech
November 26, 2024 at 3:51 AM
trialkeyai.bsky.social
Explainable AI for actionable insights! TrialKey goes beyond data analysis to uncover true drivers of trial success. Empowered with insights, your team can make confident decisions.

Book a demo today: appt.link/minhthu

#clinicaltrials #explainableai #medtech
December 23, 2024 at 1:46 AM
trialkeyai.bsky.social
Quality matters in medicinal cannabis research. With Phenix Health’s Compendium, TrialKey provides AI-reviewed validations on 900+ cannabinoid products, supporting informed decisions for chronic pain, mental health, and more.

Try a demo: appt.link/minhthu

#ai #trialkey #clinicalinsights
January 2, 2025 at 1:50 AM
trialkeyai.bsky.social
Precision data, powered by NLP. TrialKey uses NLP to bridge data gaps, linking insights from similar trials and building a complete model for your study. Discover precision-driven trial planning.

Book a demo today: appt.link/minhthu

#clinicaltrials #nlp #datascience
December 31, 2024 at 2:19 AM
trialkeyai.bsky.social
Why settle for uncertainty? TrialKey simulates trials up to 100,000 times, providing insights on outcomes, risks, and success factors. Make data-driven decisions that drive trial success.

Book a demo: appt.link/minhthu

#clinicalprecision #trialsimulation #medtech
December 1, 2024 at 11:30 PM
trialkeyai.bsky.social
A great kick-off to JP Morgan Healthcare Week! Opyl attended the Global Vic’s Welcome Reception in San Francisco to network with Australian and US senior executives in healthcare.

#biotech #medtech #opyl #trialkey #globalvic #jpmorganhealthcareweek #healthcare
January 13, 2025 at 3:10 AM
trialkeyai.bsky.social
Health Check: New JV for Opyl; Dimerix inks another licensing deal - Stockhead
Opyl has entered a joint venture with X Firm to market its TrialKey platform in key markets, while Dimerix has inked another licensing deal.
stockhead.com.au
January 7, 2025 at 4:09 AM
trialkeyai.bsky.social
Dr Minh-Thu Cao Xuan will proudly represent team Opyl at BIO-Europe Spring 2025, taking place from March 17–19 in Milan, Italy. enquire about our FREE Preliminary Reports, visit appt.link/minhthu #BIOEuropeSpring #opyl #trialkey #biotech #BIO #biopharma #clinicaltrials
February 2, 2025 at 11:39 PM
trialkeyai.bsky.social
Simulate for success! TrialKey runs each trial up to 100,000 times, achieving 92% accuracy in phase predictions and identifying key success factors. Make confident, data-driven decisions and minimise risks.

See it in action: appt.link/minhthu

#medtech #healthtech
January 5, 2025 at 11:25 PM
asx-news-en.bsky.social
Opyl partners with X Firm to transform clinical trials with AI-powered Tria... - published 06 Jan 2025 #ClinicalTrials #ASX #Africa #Tech #Strategic
Opyl partners with X Firm to transform clinical trials with AI-powered TrialKey
Opyl <a href='https://grafa.com/asset/opyl-ltd-8926-opl.asx'>(ASX:OPL)</a> announced a joint venture with X Firm, formalising a strategic framework initially
grafa.com
January 6, 2025 at 10:08 PM
longtail-news.bsky.social
Feed: "Small Caps"
By: Isla Campbell on Thursday, April 2, 2026
Pathkey.AI Lands Largest Contract Yet for TrialKey Platform with Imunexus Therapeutics
Pathkey.AI lands its biggest deal yet with Imunexus for TrialKey, up to $100k (incl. $25k upfront); remainder tied to capital raises—1-year pact.
smallcaps.com.au
April 2, 2026 at 5:37 AM
longtail-news.bsky.social
Feed: "Small Caps"
By: Nik Hill on Tuesday, September 9, 2025
Pathkey.AI Validates TrialKey With Strong Alignment To Clinical Outcomes
Pathkey.AI (ASX: PKY) has unveiled its first validation study of the TrialKey platform, an AI tool to predict clinical trial success. The company reported
smallcaps.com.au
September 9, 2025 at 9:09 PM
asx-news-de.bsky.social
Opyl geht eine Partnerschaft mit X Firm ein, um klinische Studien mit der K... - published 06 Jan 2025 #ASX #Tech #Grafa
Opyl geht eine Partnerschaft mit X Firm ein, um klinische Studien mit der KI-gesteuerten TrialKey zu transformieren.
Opyl <a href='https://grafa.com/asset/opyl-ltd-8926-opl.asx'>(ASX:OPL)</a> kündigte ein Joint Venture mit X Firm an, das einen strategischen Rahmen formalisi
grafa.com
January 6, 2025 at 10:08 PM
trialkeyai.bsky.social
TrialKey is proud to be participating in the ARCS Annual Conference on June 4th at ICC Sydney as part of the expert panel discussion, “AI in Action: Bridging Innovation and Practicality in Clinical Trials.”
#ARCS2025 #asx #biotech #opyl #trialkey #clinicaltrials #medicalresearch #drugdiscovery
May 5, 2025 at 1:18 AM
trialkeyai.bsky.social
Thank you for joining our “Enhancing Clinical Trials From Strategy to Execution” webinar, cohosted by Opyl, and Biointelect.
​
Watch the recording: youtu.be/MaGyugFMsfI
Book a TrialKey consultation: appt.link/minhthu
​
#CRO #saas #aisaas #biotech #clinicaltrials #ai #biotechnews #aitrends
April 9, 2025 at 12:57 AM
trialkeyai.bsky.social
Opyl is attending BIO Korea 2025 (7–9 May, Seoul) as part of the Australian delegation. Dr Minh-Thu Cao Xuan will represent Opyl and showcase TrialKey.
Connect via the BIO Korea 2025 partnering platform

#BIOKorea #BIOkorea2025 #biotech #asx #aiinhealthcare #biotechnews
April 6, 2025 at 10:48 PM
trialkeyai.bsky.social
Elevate your proposal game with TrialKey! CROs benefit from an AI-driven preliminary report featuring competitor benchmarking & visual insights. Secure your edge in trial execution.

Book a demo: appt.link/minhthu

#cro #clinicalresearch #trialoptimisation #trialkey
December 17, 2024 at 12:08 AM
trialkeyai.bsky.social
TrialKey forecasts duration, patient dropout, and adverse events to give you a complete trial analysis. Avoid costly amendments and make informed decisions.

Book a demo today: appt.link/minhthu

#clinicaltrials #datadrivendecisions #trialanalytics #medtech #clinicalsuccess #healthinnovation
December 3, 2024 at 10:21 PM